Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Fibrin Patch: Phase II/III start

In 1Q08, OMRI will begin a pivotal, U.S. Phase II/III trial in

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE